Brandywine Managers’s 10x Genomics TXG Stock Holding History

Brandywine Managers’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$402K	Hold	18,938	–	–	0.24%	32
2025 Q4	$309K	Hold	18,938	–	–	0.15%	36
2025 Q3	$221K	Hold	18,938	–	–	0.21%	35
2025 Q2	$219K	Hold	18,938	–	–	0.22%	32
2025 Q1	$165K	Buy	18,938 +8,865	+88%	+$112K	0.2%	33
2024 Q4	$145K	Hold	10,073	–	–	0.15%	36
2024 Q3	$227K	Hold	10,073	–	–	0.24%	33
2024 Q2	$196K	Hold	10,073	–	–	0.21%	34
2024 Q1	$378K	Hold	10,073	–	–	0.37%	29
2023 Q4	$564K	Sell	10,073 -1,135	-10%	-$49.4K	0.62%	27
2023 Q3	$462K	Hold	11,208	–	–	0.78%	27
2023 Q2	$626K	Hold	11,208	–	–	0.41%	30
2023 Q1	$625K	Hold	11,208	–	–	0.44%	27
2022 Q4	$408K	Hold	11,208	–	–	1.43%	25
2022 Q3	$319K	Buy	11,208 +2,967	+36%	+$113K	1.05%	29
2022 Q2	$373K	Hold	8,241	–	–	0.91%	28
2022 Q1	$627K	Buy	8,241 +1,024	+14%	+$89.6K	1.08%	25
2021 Q4	$1.07M	Hold	7,217	–	–	1.22%	14
2021 Q3	$1.05M	Hold	7,217	–	–	1.1%	18
2021 Q2	$1.41M	Hold	7,217	–	–	1.61%	13
2021 Q1	$1.31M	Buy	7,217 +2,917	+68%	+$504K	1.74%	11
2020 Q4	$609K	Hold	4,300	–	–	0.84%	25
2020 Q3	$536K	Hold	4,300	–	–	1.02%	18
2020 Q2	$384K	Hold	4,300	–	–	1.58%	24
2020 Q1	$268K	Hold	4,300	–	–	0.09%	24
2019 Q4	$328K	Hold	4,300	–	–	0.1%	36
2019 Q3	$217K	Buy	+4,300	New	+$238K	0.07%	44

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brandywine Managers's TXG Position: Q1 2026 in Review

Brandywine Managers held its 10x Genomics (TXG) position steady in Q1 2026 at 18,938 shares worth $402K. The position accounts for 0.24% of the portfolio, ranked #32.

Brandywine Managers first reported a position in TXG in Q3 2019 and has held it in 27 quarters since. The position peaked at $1.41M in Q2 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Brandywine Managers held 18,938 shares of 10x Genomics worth $402K as of Q1 2026.
Brandywine Managers left its 10x Genomics share count unchanged in Q1 2026.
10x Genomics made up 0.24% of Brandywine Managers's portfolio in Q1 2026, its #32 holding.
Brandywine Managers first reported a position in 10x Genomics in Q3 2019 and has held it in 27 quarters since.
Brandywine Managers's 10x Genomics position peaked at $1.41M in Q2 2021.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Brandywine Managers's 13F filing for Q1 2026, filed 14 May 2026.